Tibra Equities Europe’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,300	Closed	-$250K	–	30
2021 Q3	$250K	Buy	+14,300	New	+$250K	0.38%	29
2019 Q2	–	Sell	-25,401	Closed	-$727K	–	357
2019 Q1	$727K	Buy	+25,401	New	+$727K	0.07%	213